Monogram Biosciences, Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA and is a subsidiary of LabCorp.
Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.
The company went public (NASDAQ: VLGC) in 2000.
[2] Monogram was acquired by Laboratory Corporation of America in June 2009.
[3] This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.